Abiopharma

CENTOGENE N.V. (CNTGF)

Symbol	CNTGF
Name	CENTOGENE N.V.
Sector	UNDEFINED
Region	Europe
Industry	-
Address	18055 Germany Am Strande 7
Telephone	+49 173 79 40 879
Fax	—
Email	—
Website	http://www.centogene.com/
Incorporation	NL
Incorporated On	2018
Employees	—
Fiscal Year	12/31
Public Since	—
Exchanges	OTC
Auditor	Ernst & Young LLP;
Audit Status	AUDITED
Reporting Status	U.S. Reporting: SEC Reporting
CIK	0001757097
Description	CENTOGENEs mission is to provide data-driven, life-changing answers to patients, physicians, and pharma companies for rare and neurodegenerative diseases. We integrate multiomic technologies with the CENTOGENE Biodatabank - providing dimensional analysis to guide the next generation of precision medicine. Our unique approach enables rapid and reliable diagnosis for patients, supports a more precise physician understanding of disease states, and accelerates and de-risks targeted pharma drug discovery, development, and commercialization. Additional info from OTC: CENTOGENEs mission is to provide data-driven, life-changing answers to patients, physicians, and pharma companies for rare and neurodegenerative diseases. We integrate multiomic technologies with the CENTOGENE Biodatabank - providing dimensional analysis to guide the next generation of precision medicine. Our unique approach enables rapid and reliable diagnosis for patients, supports a more precise physician understanding of disease states, and accelerates and de-risks targeted pharma drug discovery, development, and commercialization.

2024-11-13 11:30

CENTOGENE Signs Strategic Transaction With Private Equity Group Charme Capital Partners

2024-09-25 12:01

CENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology

2024-08-28 07:16

Pink Current symbol attribute type Security_Name was changed. Previous value: -. New value: CENTOGENE N V.

2024-08-27 08:15

OTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: CENTOGENE N V.

2024-08-08 08:44

Centogene N.V. (CNTGF) was added to the list of traded instruments on Pink Current exchange

2024-08-07 22:20

CENTOGENE Receives Delisting Notice From Nasdaq

2024-08-01 20:16

CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson’s Disease Cases Are Linked to Genetic Factors

2024-04-02 20:31

CENTOGENE Receives Nasdaq Non-Compliance Notice

2024-03-19 10:31

CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders